HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yijun Fan Selected Research

Borna Disease

11/2013Prospects for cannabinoid therapies in viral encephalitis.
11/2010A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yijun Fan Research Topics

Disease

16Infections
01/2015 - 01/2002
10Inflammation (Inflammations)
11/2013 - 01/2002
6Asthma (Bronchial Asthma)
04/2011 - 01/2002
5Hypersensitivity (Allergy)
01/2012 - 04/2004
4Neoplasms (Cancer)
01/2022 - 12/2016
4Bacterial Infections (Bacterial Infection)
01/2015 - 01/2002
4Eosinophilia
04/2011 - 03/2002
2Carcinoma (Carcinomatosis)
12/2016 - 03/2016
2Virus Diseases (Viral Diseases)
11/2013 - 11/2010
2Viral Encephalitis
11/2013 - 11/2010
2Borna Disease
11/2013 - 11/2010
2Chlamydia Infections
04/2010 - 05/2006
2Pneumonia (Pneumonitis)
02/2009 - 01/2002
2Hyperplasia
09/2007 - 07/2007
2Necrosis
02/2005 - 04/2004
1Rheumatoid Arthritis
01/2022
1Endometrial Neoplasms (Endometrial Cancer)
01/2022
1Poisoning
08/2018
1Stress Urinary Incontinence
08/2015
1Postoperative Pain
08/2015
1Diabetes Mellitus
03/2015
1Body Weight Changes
01/2015
1Sarcoma 180
07/2014
1Marijuana Abuse (Cannabis Abuse)
06/2014
1Schizophrenia (Dementia Praecox)
06/2014
1Weight Loss (Weight Reduction)
03/2014
1Disease Progression
11/2013
1Respiratory Hypersensitivity
04/2011
1Tuberculosis (Tuberculoses)
02/2010
1Body Weight (Weight, Body)
11/2009
1Chronic Disease (Chronic Diseases)
10/2007
1Type 2 Diabetes Mellitus (MODY)
08/2006

Drug/Important Bio-Agent (IBA)

12CytokinesIBA
03/2014 - 03/2002
10AllergensIBA
06/2010 - 01/2002
5LigandsIBA
04/2011 - 02/2004
4Interleukin-12 (IL 12)IBA
01/2012 - 04/2004
4Immunoglobulin E (IgE)IBA
04/2011 - 01/2002
4OvalbuminIBA
04/2011 - 01/2002
4Interleukin-4 (Interleukin 4)IBA
01/2007 - 02/2004
3Interleukin-13IBA
09/2007 - 04/2004
2Monoclonal AntibodiesIBA
01/2022 - 03/2014
2Polysaccharides (Glycans)IBA
03/2015 - 07/2014
2CannabinoidsIBA
06/2014 - 11/2013
2Cannabinoid Receptor AgonistsIBA
11/2013 - 11/2010
2Interleukin-10 (Interleukin 10)IBA
06/2010 - 04/2004
2VaccinesIBA
02/2010 - 09/2007
2Immunoglobulin G (IgG)IBA
11/2006 - 01/2002
2alpha-galactosylceramideIBA
09/2005 - 02/2004
2ChemokinesIBA
02/2004 - 03/2002
1Methotrexate (Mexate)FDA LinkGeneric
01/2022
1golimumabFDA Link
01/2022
1NucleotidesIBA
01/2022
1Histocompatibility Antigens Class IIBA
01/2022
1Trans-Activators (Trans-Acting Factor)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1N-methyladenosineIBA
01/2021
1NLR ProteinsIBA
05/2020
1ParaquatIBA
08/2018
1CarcinogensIBA
12/2016
1Indicators and Reagents (Reagents)IBA
03/2016
1Interleukin-9 (Interleukin 9)IBA
01/2015
1Dopamine (Intropin)FDA LinkGeneric
06/2014
1Interleukin-22 (IL-22)IBA
03/2014
1CB2 Cannabinoid ReceptorIBA
11/2013
1(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
11/2013
1Neuroprotective AgentsIBA
11/2013
1HU 308IBA
11/2013
1Immunoglobulin IsotypesIBA
04/2011
1anandamide (arachidonylethanolamide)IBA
11/2010
1EndocannabinoidsIBA
11/2010
1Interleukin-17 (Interleukin 17)IBA
11/2009
1salicylhydroxamic acid (SHAM)IBA
11/2009
1Lymphotoxin-alpha (Lymphotoxin)IBA
10/2007
1Peptides (Polypeptides)IBA
09/2007
1Methacholine Chloride (Methacholine)FDA Link
09/2007
1InterleukinsIBA
09/2007
1Pharmaceutical PreparationsIBA
08/2006
1LipopolysaccharidesIBA
02/2005
1CXC ChemokinesIBA
02/2005
1Chemokine CXCL2IBA
02/2005
1Interleukin-1 (Interleukin 1)IBA
02/2005
1Interleukin-6 (Interleukin 6)IBA
02/2005
1Interleukin-5 Receptors (Interleukin 5 Receptor)IBA
04/2004
1Interleukin-5 (Interleukin 5)IBA
04/2004
1Interferon-gamma (Interferon, gamma)IBA
04/2004
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
03/2002
1aluminum sulfate (alum)IBA
03/2002

Therapy/Procedure

4Therapeutics
01/2022 - 08/2006
2Immunotherapy
01/2022 - 01/2021
1Hemoperfusion
08/2018
1Continuous Renal Replacement Therapy
08/2018
1Drug Therapy (Chemotherapy)
12/2016
1Suburethral Slings (Tension-Free Vaginal Tape)
08/2015
1Intranasal Administration
03/2014